| Dr Alina H Waring, MD | |
|
100 Central St, Chillicothe, MO 64601-1554 | |
| (660) 646-1480 | |
| Not Available |
| Full Name | Dr Alina H Waring |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 100 Central St, Chillicothe, Missouri |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790759413 | NPI | - | NPPES |
| 100425550A | Medicaid | KS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 04-26030 (Kansas) | Secondary |
| 207P00000X | Emergency Medicine | 100956 (Missouri) | Primary |
| Entity Name | Saint Luke's Hospital Of Trenton |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841274057 PECOS PAC ID: 3971495532 Enrollment ID: O20040327000339 |
News Archive
Infinity Pharmaceuticals, Inc. today reported preclinical data for IPI-145, the company's oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma. The data demonstrate potent PI3K-delta and -gamma inhibition in biochemical, cellular and whole blood assays and activity in multiple preclinical models of inflammatory disease, including rheumatoid arthritis and asthma.
A new study reports this finding, along with varying antibody prevalence among different groups and regions and between different age groups. In the current paper, available as a preprint on the medRxiv* server, the results of the sixth round of the REACT-2 study are reported.
Ischaemic heart disease, characterised by reduced blood flow to the heart, is Australia's and the world's leading cause of death.
Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and anti-infective coatings for medical applications, expects to report its seventh consecutive quarter of record revenue growth.
› Verified 3 days ago
| Entity Name | Saint Lukes Hospital Of Chillicothe |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245433127 PECOS PAC ID: 0143130393 Enrollment ID: O20041014000548 |
News Archive
Infinity Pharmaceuticals, Inc. today reported preclinical data for IPI-145, the company's oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma. The data demonstrate potent PI3K-delta and -gamma inhibition in biochemical, cellular and whole blood assays and activity in multiple preclinical models of inflammatory disease, including rheumatoid arthritis and asthma.
A new study reports this finding, along with varying antibody prevalence among different groups and regions and between different age groups. In the current paper, available as a preprint on the medRxiv* server, the results of the sixth round of the REACT-2 study are reported.
Ischaemic heart disease, characterised by reduced blood flow to the heart, is Australia's and the world's leading cause of death.
Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and anti-infective coatings for medical applications, expects to report its seventh consecutive quarter of record revenue growth.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alina H Waring, MD 920 Main St Ste 300, Kansas City, MO 64105-2008 Ph: (816) 561-1025 | Dr Alina H Waring, MD 100 Central St, Chillicothe, MO 64601-1554 Ph: (660) 646-1480 |
News Archive
Infinity Pharmaceuticals, Inc. today reported preclinical data for IPI-145, the company's oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma. The data demonstrate potent PI3K-delta and -gamma inhibition in biochemical, cellular and whole blood assays and activity in multiple preclinical models of inflammatory disease, including rheumatoid arthritis and asthma.
A new study reports this finding, along with varying antibody prevalence among different groups and regions and between different age groups. In the current paper, available as a preprint on the medRxiv* server, the results of the sixth round of the REACT-2 study are reported.
Ischaemic heart disease, characterised by reduced blood flow to the heart, is Australia's and the world's leading cause of death.
Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and anti-infective coatings for medical applications, expects to report its seventh consecutive quarter of record revenue growth.
› Verified 3 days ago
Dr. Antoinette Adowaa Kotey, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 100 Central St, Chillicothe, MO 64601 Phone: 660-707-4291 |